Skip to main content
OpenTrials
Completed

NCT Number: NCT01182142

Study of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma (RCC) Patients

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. The role of capecitabine in treatment of metastatic renal cell carcinoma is discussed. In this trial, we are evaluating efficacy of capecitabine in metastatic renal cell carcinoma patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Metastatic Renal Cell Carcinoma Adenocarcinoma Carcinoma Carcinoma, Renal Cell Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Kidney Neoplasms Male Urogenital Diseases Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial Urogenital Diseases Urogenital Neoplasms Urologic Diseases Urologic Neoplasms

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Natalia Petenko

Moscow, Russia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • histologically confirmed non-clear cell renal cell carcinoma
  • confirmed metastatic sites
  • no chemotherapy in history

Exclusion criteria

  • metastases in CNS
  • previous targeted therapy
  • other tumor

Treatment and study plan

Capecitabine

Drug

1,250 mg/m2 orally twice a day, days 1-14

Primary outcomes

  1. Overall response rate

    Time frame: 12 months

Secondary outcomes

  1. Overall survival Progression-free survival

    Time frame: 24 months

Sponsors and collaborators

Lead sponsor

Kidney Cancer Research Bureau

Other

Registry information

Official study title

Phase II Study of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma Patients

Important dates

Study start
2007
Primary completion
2009
Study completion
2010
First posted
Aug 16, 2010
Registry last updated
Aug 24, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.